BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12393547)

  • 1. Convergence of the adhesive and fibrinolytic systems: recognition of urokinase by integrin alpha Mbeta 2 as well as by the urokinase receptor regulates cell adhesion and migration.
    Pluskota E; Soloviev DA; Plow EF
    Blood; 2003 Feb; 101(4):1582-90. PubMed ID: 12393547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
    Tarui T; Akakura N; Majumdar M; Andronicos N; Takagi J; Mazar AP; Bdeir K; Kuo A; Yarovoi SV; Cines DB; Takada Y
    Thromb Haemost; 2006 Mar; 95(3):524-34. PubMed ID: 16525582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling.
    Tarui T; Andronicos N; Czekay RP; Mazar AP; Bdeir K; Parry GC; Kuo A; Loskutoff DJ; Cines DB; Takada Y
    J Biol Chem; 2003 Aug; 278(32):29863-72. PubMed ID: 12754207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
    Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
    J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.
    Wei Y; Eble JA; Wang Z; Kreidberg JA; Chapman HA
    Mol Biol Cell; 2001 Oct; 12(10):2975-86. PubMed ID: 11598185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin alphaMbeta2 orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils.
    Pluskota E; Soloviev DA; Bdeir K; Cines DB; Plow EF
    J Biol Chem; 2004 Apr; 279(17):18063-72. PubMed ID: 14769799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells.
    Simon DI; Rao NK; Xu H; Wei Y; Majdic O; Ronne E; Kobzik L; Chapman HA
    Blood; 1996 Oct; 88(8):3185-94. PubMed ID: 8874219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration.
    Yebra M; Parry GC; Strömblad S; Mackman N; Rosenberg S; Mueller BM; Cheresh DA
    J Biol Chem; 1996 Nov; 271(46):29393-9. PubMed ID: 8910604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of the urokinase-type plasminogen activator receptor (uPAR) in neutrophil transendothelial migration.
    Pliyev BK; Antonova OA; Menshikov M
    Mol Immunol; 2011 May; 48(9-10):1168-77. PubMed ID: 21470685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells.
    Alfano M; Mariani SA; Elia C; Pardi R; Blasi F; Poli G
    Blood; 2009 Feb; 113(8):1699-709. PubMed ID: 18941116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of integrin alpha M beta 2 ligand-binding function by the urokinase-type plasminogen activator receptor.
    Tang ML; Kong LS; Law SK; Tan SM
    Biochem Biophys Res Commun; 2006 Sep; 348(3):1184-93. PubMed ID: 16905120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium.
    Cao D; Mizukami IF; Garni-Wagner BA; Kindzelskii AL; Todd RF; Boxer LA; Petty HR
    J Immunol; 1995 Feb; 154(4):1817-29. PubMed ID: 7836767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.
    Yebra M; Goretzki L; Pfeifer M; Mueller BM
    Exp Cell Res; 1999 Jul; 250(1):231-40. PubMed ID: 10388537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.
    Franco P; Vocca I; Carriero MV; Alfano D; Cito L; Longanesi-Cattani I; Grieco P; Ossowski L; Stoppelli MP
    J Cell Sci; 2006 Aug; 119(Pt 16):3424-34. PubMed ID: 16882693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice.
    Jo M; Takimoto S; Montel V; Gonias SL
    Am J Pathol; 2009 Jul; 175(1):190-200. PubMed ID: 19497996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes.
    Sitrin RG; Todd RF; Albrecht E; Gyetko MR
    J Clin Invest; 1996 Apr; 97(8):1942-51. PubMed ID: 8621779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
    Plesner T; Behrendt N; Ploug M
    Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion.
    Bonavaud S; Charrière-Bertrand C; Rey C; Leibovitch MP; Pedersen N; Frisdal E; Planus E; Blasi F; Gherardi R; Barlovatz-Meimon G
    J Cell Sci; 1997 May; 110 ( Pt 9)():1083-9. PubMed ID: 9175704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.
    May AE; Kanse SM; Lund LR; Gisler RH; Imhof BA; Preissner KT
    J Exp Med; 1998 Sep; 188(6):1029-37. PubMed ID: 9743521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clustering of urokinase receptors (uPAR; CD87) induces proinflammatory signaling in human polymorphonuclear neutrophils.
    Sitrin RG; Pan PM; Harper HA; Todd RF; Harsh DM; Blackwood RA
    J Immunol; 2000 Sep; 165(6):3341-9. PubMed ID: 10975852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.